Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for HCC

Summary

This is a prospective, single-center, phase II study，to evaluate the efficacy and safety of icariin soft capsules combined with TACE as adjuvant therapy in hepatocellular carcinoma (HCC) patients at high risk of recurrence after resection.

Timeline

Start

2025-03-30

Primary completion

2026-06-01

Completion

2027-02-28

Drugs

Indications